News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innovus Pharma Secures $0.5M Commitment From Its Chief Executive Officer


3/20/2013 9:49:11 AM

LA JOLLA, Calif., March 20, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced that it received a $0.5M funding commitment from its President and Chief Executive Officer, Dr. Bassam Damaj. In connection with this commitment, the Company's independent registered public accounting firm has issued its audit opinion on the Company's 2012 and 2011 financial statements free of a "going concern" qualification.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES